Related references
Note: Only part of the references are listed.Endogenous T Cell Responses to Antigens Expressed in Lung Adenocarcinomas Delay Malignant Tumor Progression
Michel DuPage et al.
CANCER CELL (2011)
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
Michel DuPage et al.
NATURE PROTOCOLS (2009)
Regulated Expression of a Tumor-Associated Antigen Reveals Multiple Levels of T-Cell Tolerance in a Mouse Model of Lung Cancer
Ann F. Cheung et al.
CANCER RESEARCH (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy (vol 28, pg 571, 2008)
Nadia Guerra et al.
IMMUNITY (2008)
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
Jeremy B. Swann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
A spatially and temporally restricted mouse model of soft tissue sarcoma
David G. Kirsch et al.
NATURE MEDICINE (2007)
A mutant chaperone converts a wild-type protein into a tumor-specific antigen
Andrea Schietinger et al.
SCIENCE (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model
ZS Guo et al.
CANCER RESEARCH (2006)
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
G Willimsky et al.
NATURE (2005)
Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression
G Zhou et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Natural selection of tumor variants in the generation of tumor escape phenotypes
HT Khong et al.
NATURE IMMUNOLOGY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
The SSX gene family:: Characterization of 9 complete genes
AO Güre et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Share Paper
